Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
MPLX LP has a consensus price target of $49.53 based on the ratings of 15 analysts. The high is $62 issued by Morgan Stanley on March 11, 2025. The low is $36 issued by Citigroup on July 12, 2023. The 3 most-recent analyst ratings were released by RBC Capital, Barclays, and Morgan Stanley on March 17, 2025, March 14, 2025, and March 11, 2025, respectively. With an average price target of $58.33 between RBC Capital, Barclays, and Morgan Stanley, there's an implied 8.27% upside for MPLX LP from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/17/2025 | Buy Now | 7.65% | RBC Capital | Elvira Scotto48% | $55 → $58 | Maintains | Outperform | Get Alert |
03/14/2025 | Buy Now | 2.08% | Barclays | Theresa Chen77% | $52 → $55 | Maintains | Overweight | Get Alert |
03/11/2025 | Buy Now | 15.07% | Morgan Stanley | Robert Kad77% | $56 → $62 | Maintains | Equal-Weight | Get Alert |
02/06/2025 | Buy Now | 11.36% | Raymond James | Justin Jenkins78% | $55 → $60 | Maintains | Outperform | Get Alert |
02/06/2025 | Buy Now | 9.5% | Wells Fargo | Michael Blum68% | $54 → $59 | Maintains | Overweight | Get Alert |
01/13/2025 | Buy Now | -3.49% | Barclays | Theresa Chen77% | $49 → $52 | Maintains | Overweight | Get Alert |
12/18/2024 | Buy Now | 0.22% | Wells Fargo | Michael Blum68% | $53 → $54 | Maintains | Overweight | Get Alert |
11/19/2024 | Buy Now | 2.08% | Truist Securities | Neal Dingmann65% | $48 → $55 | Maintains | Buy | Get Alert |
11/18/2024 | Buy Now | -3.49% | RBC Capital | Elvira Scotto48% | $50 → $52 | Maintains | Outperform | Get Alert |
11/15/2024 | Buy Now | 2.08% | UBS | Brian Reynolds81% | $51 → $55 | Maintains | Buy | Get Alert |
11/07/2024 | Buy Now | -1.63% | Wells Fargo | Michael Blum68% | $50 → $53 | Maintains | Overweight | Get Alert |
10/17/2024 | Buy Now | -20.19% | B of A Securities | Jean Ann Salisbury59% | → $43 | Reinstates | → Underperform | Get Alert |
10/16/2024 | Buy Now | -7.2% | RBC Capital | Elvira Scotto48% | $47 → $50 | Maintains | Outperform | Get Alert |
10/10/2024 | Buy Now | -9.06% | Barclays | Theresa Chen77% | $45 → $49 | Maintains | Overweight | Get Alert |
09/18/2024 | Buy Now | -5.35% | UBS | Brian Reynolds81% | $49 → $51 | Maintains | Buy | Get Alert |
09/16/2024 | Buy Now | -16.48% | Barclays | Theresa Chen77% | $46 → $45 | Maintains | Overweight | Get Alert |
08/28/2024 | Buy Now | -12.77% | RBC Capital | Elvira Scotto48% | $47 → $47 | Reiterates | Outperform → Outperform | Get Alert |
08/07/2024 | Buy Now | -7.2% | Wells Fargo | Michael Blum68% | $47 → $50 | Maintains | Overweight | Get Alert |
07/12/2024 | Buy Now | -16.48% | Barclays | Christine Cho49% | $43 → $45 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | -14.63% | JP Morgan | Jeremy Tonet66% | $45 → $46 | Maintains | Overweight | Get Alert |
05/02/2024 | Buy Now | -10.91% | Truist Securities | Neal Dingmann65% | $43 → $48 | Maintains | Buy | Get Alert |
05/01/2024 | Buy Now | -12.77% | Stifel | Selman Akyol72% | $45 → $47 | Maintains | Buy | Get Alert |
04/12/2024 | Buy Now | -9.06% | UBS | Brian Reynolds81% | $46 → $49 | Maintains | Buy | Get Alert |
04/05/2024 | Buy Now | -20.19% | Barclays | Christine Cho49% | $40 → $43 | Maintains | Overweight | Get Alert |
03/01/2024 | Buy Now | -14.63% | UBS | Joseph Parkhill75% | $44 → $46 | Maintains | Buy | Get Alert |
01/31/2024 | Buy Now | -16.48% | Raymond James | Justin Jenkins78% | $44 → $45 | Maintains | Outperform | Get Alert |
01/31/2024 | Buy Now | -14.63% | RBC Capital | Elvira Scotto48% | $45 → $46 | Maintains | Outperform | Get Alert |
10/06/2023 | Buy Now | -25.76% | Goldman Sachs | John Mackay75% | → $40 | Reinstates | → Buy | Get Alert |
08/16/2023 | Buy Now | -22.05% | Stifel | Selman Akyol72% | $40 → $42 | Maintains | Buy | Get Alert |
07/21/2023 | Buy Now | -18.34% | Raymond James | Justin Jenkins78% | $42 → $44 | Maintains | Outperform | Get Alert |
07/20/2023 | Buy Now | -22.05% | Morgan Stanley | Robert Kad77% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/12/2023 | Buy Now | -33.18% | Citigroup | Spiro Dounis79% | → $36 | Reiterates | Neutral → Neutral | Get Alert |
07/11/2023 | Buy Now | -22.05% | Morgan Stanley | Robert Kad77% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
05/03/2023 | Buy Now | -22.05% | Raymond James | Justin Jenkins78% | $40 → $42 | Maintains | Outperform | Get Alert |
04/25/2023 | Buy Now | -22.05% | Morgan Stanley | Robert Kad77% | $41 → $42 | Maintains | Equal-Weight | Get Alert |
04/21/2023 | Buy Now | -25.76% | Raymond James | Justin Jenkins78% | $41 → $40 | Maintains | Outperform | Get Alert |
04/05/2023 | Buy Now | -29.47% | Barclays | Theresa Chen77% | $37 → $38 | Maintains | Overweight | Get Alert |
03/14/2023 | Buy Now | -23.9% | JP Morgan | Jeremy Tonet66% | $37 → $41 | Upgrade | Neutral → Overweight | Get Alert |
02/07/2023 | Buy Now | -35.04% | Citigroup | Spiro Dounis79% | $33.5 → $35 | Maintains | Neutral | Get Alert |
02/01/2023 | Buy Now | -23.9% | Raymond James | Justin Jenkins78% | $40 → $41 | Maintains | Outperform | Get Alert |
01/09/2023 | Buy Now | -23.9% | Morgan Stanley | Robert Kad77% | $39 → $41 | Maintains | Equal-Weight | Get Alert |
01/09/2023 | Buy Now | -33.18% | Wolfe Research | Keith Stanley49% | → $36 | Upgrade | Peer Perform → Outperform | Get Alert |
12/09/2022 | Buy Now | -37.82% | Citigroup | Spiro Dounis79% | → $33.5 | Initiates | → Neutral | Get Alert |
11/07/2022 | Buy Now | -25.76% | Wells Fargo | Michael Blum68% | $41 → $40 | Maintains | Overweight | Get Alert |
11/02/2022 | Buy Now | -25.76% | Raymond James | Justin Jenkins78% | $39 → $40 | Maintains | Outperform | Get Alert |
07/08/2022 | Buy Now | -25.76% | UBS | Joseph Parkhill75% | $41 → $40 | Maintains | Buy | Get Alert |
05/02/2022 | Buy Now | -31.33% | Truist Securities | Neal Dingmann65% | → $37 | Assumes | → Buy | Get Alert |
04/28/2022 | Buy Now | -23.9% | Wells Fargo | Michael Blum68% | $37 → $41 | Maintains | Overweight | Get Alert |
04/26/2022 | Buy Now | -27.62% | Morgan Stanley | Robert Kad77% | $37 → $39 | Maintains | Equal-Weight | Get Alert |
04/20/2022 | Buy Now | -27.62% | Raymond James | Justin Jenkins78% | $37 → $39 | Maintains | Outperform | Get Alert |
The latest price target for MPLX (NYSE:MPLX) was reported by RBC Capital on March 17, 2025. The analyst firm set a price target for $58.00 expecting MPLX to rise to within 12 months (a possible 7.65% upside). 24 analyst firms have reported ratings in the last year.
The latest analyst rating for MPLX (NYSE:MPLX) was provided by RBC Capital, and MPLX maintained their outperform rating.
The last upgrade for MPLX LP happened on March 14, 2023 when JP Morgan raised their price target to $41. JP Morgan previously had a neutral for MPLX LP.
There is no last downgrade for MPLX.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MPLX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MPLX was filed on March 17, 2025 so you should expect the next rating to be made available sometime around March 17, 2026.
While ratings are subjective and will change, the latest MPLX (MPLX) rating was a maintained with a price target of $55.00 to $58.00. The current price MPLX (MPLX) is trading at is $53.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.